Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Pierluigi Porcu

Early CTCL Diagnosis, a (miR)age No More?

Blood

English

Non-Hodgkin's Lymphomas

Journal of the National Comprehensive Cancer Network : JNCCN

Medicine

Oncology

2011

English

Phase 2 Trial of Rituximab and Bortezomib in Patients With Relapsed or Refractory Mantle Cell and Follicular Lymphoma

English

Duvelisib, an Oral Dual PI3K-δ,γ Inhibitor, Shows Clinical and Pharmacodynamic Activity in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma in a Phase 1 Study

American Journal of Hematology

Hematology

2018

English

Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) and Resting Lymphocyte Kinase (RLK) Using a Novel Covalent Inhibitor PRN694

Journal of Biological Chemistry

English

Promoter Methylation RegulatesSAMHD1Gene Expression in Human CD4+T Cells

Journal of Biological Chemistry

English

Downregulation of SAMHD1 Expression Correlates With Promoter DNA Methylation in Sézary Syndrome Patients

Journal of Investigative Dermatology

English

Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell Lymphoma

Clinical Lymphoma, Myeloma and Leukemia

English

Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of the Ohio State University

Clinical Lymphoma, Myeloma and Leukemia

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Pierluigi Porcu

Early CTCL Diagnosis, a (miR)age No More?

Non-Hodgkin's Lymphomas

Phase 2 Trial of Rituximab and Bortezomib in Patients With Relapsed or Refractory Mantle Cell and Follicular Lymphoma

Duvelisib, an Oral Dual PI3K-δ,γ Inhibitor, Shows Clinical and Pharmacodynamic Activity in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma in a Phase 1 Study

Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) and Resting Lymphocyte Kinase (RLK) Using a Novel Covalent Inhibitor PRN694

Promoter Methylation RegulatesSAMHD1Gene Expression in Human CD4+T Cells

Downregulation of SAMHD1 Expression Correlates With Promoter DNA Methylation in Sézary Syndrome Patients

Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell Lymphoma

Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of the Ohio State University